Skip Navigation



European Heart Journal Advance Access published online on May 4, 2005
European Heart Journal, doi:10.1093/eurheartj/ehi308
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
26/14/1347    most recent
ehi308v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Verma, S.
Right arrow Articles by Strauss, M. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Verma, S.
Right arrow Articles by Strauss, M. H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

European Heart Journal © The European Society of Cardiology 2005; All rights reserved

Editorial

Perindopril in diabetes: perspective from the EUROPA substudy, PERSUADE

Subodh Verma 1*, Lawrence A. Leiter 2, Eva M. Lonn 3, and Martin H. Strauss 4

1 Division of Cardiac Surgery, St Michael's Hospital and Toronto General Hospital, University of Toronto, Toronto, ON M5G 2CA, Canada; Department of Pharmacology, University of Toronto, Toronto, Ontario, Canada
2 Division of Endocrinology, St Michael's Hospital, Toronto, Ontario, Canada
3 Division of Cardiology, McMaster University, Hamilton, Ontario, Canada
4 Division of Cardiology, North York General Hospital, Toronto, Ontario, Canada

* To whom correspondence should be addressed.
Subodh Verma, E-mail: subodh.verma{at}sympatico.ca



This article has no Abstract.

The opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 CirculationHome page
M. H. Strauss and A. S. Hall
Angiotensin Receptor Blockers May Increase Risk of Myocardial Infarction: Unraveling the ARB-MI Paradox
Circulation, August 22, 2006; 114(8): 838 - 854.
[Full Text] [PDF]

Home page
 StrokeHome page
M. H. Strauss, S. Verma, J. Schrader, S. Luders, A. Kulschewski, F. Hammersen, K. Plate, J. Berger, W. Zidek, P. Dominiak, et al.
MOSES Raises Questions * Response:
Stroke, February 1, 2006; 37(2): 338 - 340.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.